A new study led by researchers at Queen Mary University of London provides potential novel biomarkers for predicting patient responsiveness
Month: October 2020
Cerebrospinal fluid as liquid biopsy for characterizing and policing of medulloblastoma
Building on previous research 1—3 led by Joan Seoane, Director of Translational Research at the Vall d’Hebron Institute of Oncology
Artificially sweetened drinks may not be heart healthier than sugary drinks
Sugary drinks and artificially sweetened beverages are associated with a higher risk of cardiovascular disease, which suggests artificially sweetened beverages
New guidelines address rise in opioid use during pregnancy
Opioid use in pregnancy has prompted new guidance from the American Academy of Pediatrics, aimed at improving care for women
Fear and anxiety spike in virus hot spots across US
Preslie Paur breaks down in tears when she thinks of her state’s refusal to mandate face masks. The South Salt
Emerging treatment helps reverse heart failure in some patients
For the more than 6.2 million Americans living with heart failure, the disease is a cruel thief. It robs patients
Nearly one in three young adults in the US does not know common stroke symptoms
At a time when stroke is on the rise among young adults, nearly 30% of U.S. adults younger than age
Germany’s Bayer to buy US gene therapy specialist AskBio
German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in
Single brain region links depression and anxiety, heart disease, and treatment sensitivity
Over-activity in a single brain region called the subgenual anterior cingulate cortex (sgACC) underlies several key symptoms of mood and
The world needs more kindness
Here is how to develop your practice. In a global pandemic, who has time to be kind? But kindness expert
